Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Q2 Holdings, Inc.QTWO · Entity 4051 | Chief Delivery Officer | March 11, 2026 | March 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Q2 Holdings, Inc.
Report date March 11, 2026 · Filed March 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 133,128 |
Ending reported balance
After 2026-03-11 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-03-11 · Sale · Disposed 8,924 · Balance 75,312 F1: The sale reported was effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on May 19, 2025. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.64 to $51.96 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-03-11 · Grant · Acquired 28,908 · Balance 104,220 F3: The restricted stock units vest 25% starting March 3, 2027, with the remaining units vesting in equal quarterly installments over the subsequent three years. Row 3 · 2026-03-11 · Grant · Acquired 11,562 · Balance 115,782 F4: Represents the target number of shares that may be earned ("Target Amount") pursuant to performance-based restricted stock units ("Units") under the 2023 Equity Incentive Plan, with vesting dependent upon Q2's attainment relative to a target performance metric for Adjusted EBITDA as a percentage of Revenue for the 12 months ending December 31, 2027, as more specifically set forth in the grant agreement. Subject to continued employment, attainment will be determined on the second anniversary of the date of grant, with any earned shares up to 100% of the Target Amount vesting on such date, and any shares issuable pursuant to above-target attainment vesting on the third anniversary of the grant date. Row 4 · 2026-03-11 · Grant · Acquired 11,562 · Balance 127,344 F5: Represents the target number of shares that may be earned ("Target Amount") pursuant to performance-based restricted stock units ("Units") under the 2023 Equity Incentive Plan, with vesting dependent upon Q2's attainment relative to a target performance metric for Subscription Revenue Year over Year Growth Revenue for the 12 months ending December 31, 2027, as more specifically set forth in the grant agreement. Subject to continued employment, attainment will be determined on the second anniversary of the date of grant, with any earned shares up to 100% of the Target Amount vesting on such date, and any shares issuable pursuant to above-target attainment vesting on the third anniversary of the grant date. Row 5 · 2026-03-11 · Grant · Acquired 5,784 · Balance 133,128 F6: Represents the target number of shares that may be earned ("Target Amount") pursuant to performance-based restricted stock units ("Units") under the 2023 Equity Incentive Plan, with vesting dependent upon Q2's attainment relative to target performance of Q2's common stock price as compared to the S&P Software & Services Select Index, as more specifically set forth in the grant agreement. Subject to continued employment, attainment will be determined on the third anniversary of the date of grant, with 0% to 200% of the Target Amount vesting on such date depending on the level of attainment. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported was effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on May 19, 2025.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.64 to $51.96 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The restricted stock units vest 25% starting March 3, 2027, with the remaining units vesting in equal quarterly installments over the subsequent three years.
F4: Represents the target number of shares that may be earned ("Target Amount") pursuant to performance-based restricted stock units ("Units") under the 2023 Equity Incentive Plan, with vesting dependent upon Q2's attainment relative to a target performance metric for Adjusted EBITDA as a percentage of Revenue for the 12 months ending December 31, 2027, as more specifically set forth in the grant agreement. Subject to continued employment, attainment will be determined on the second anniversary of the date of grant, with any earned shares up to 100% of the Target Amount vesting on such date, and any shares issuable pursuant to above-target attainment vesting on the third anniversary of the grant date.
F5: Represents the target number of shares that may be earned ("Target Amount") pursuant to performance-based restricted stock units ("Units") under the 2023 Equity Incentive Plan, with vesting dependent upon Q2's attainment relative to a target performance metric for Subscription Revenue Year over Year Growth Revenue for the 12 months ending December 31, 2027, as more specifically set forth in the grant agreement. Subject to continued employment, attainment will be determined on the second anniversary of the date of grant, with any earned shares up to 100% of the Target Amount vesting on such date, and any shares issuable pursuant to above-target attainment vesting on the third anniversary of the grant date.
F6: Represents the target number of shares that may be earned ("Target Amount") pursuant to performance-based restricted stock units ("Units") under the 2023 Equity Incentive Plan, with vesting dependent upon Q2's attainment relative to target performance of Q2's common stock price as compared to the S&P Software & Services Select Index, as more specifically set forth in the grant agreement. Subject to continued employment, attainment will be determined on the third anniversary of the date of grant, with 0% to 200% of the Target Amount vesting on such date depending on the level of attainment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2021 Filed Mar 5, 2021 21:31 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | GrantCommon Stock | 14,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001410384-21-000032 · wf-form4_161497984365720.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,284 F1 · shares: Represents the target number ("Target Amount") of performance-based restricted stock units ("Units") under the 2014 Equity Incentive Plan. Subject to continued employment, one-third of the Target Amount ("Scheduled Amount") is scheduled to vest after year two and two-thirds of the Target Amount is scheduled to vest after year three. On the second-year vest date, the number of Units that actually vests will be 0% to 100% of the Scheduled Amount and on the third-year vest date the number of Units that actually will vest will be 0% to 200% of the Target Amount, less the amount of any vesting in year two, in each case depending upon the performance of Q2 Holdings, Inc.'s common stock price as compared to the Russell 2000 Index, as more specifically set forth in the grant agreement. The maximum number of Units that may vest over three years is 200% of the Target Amount. Vested Units will be paid in an equal number of shares of Q2 Holdings, Inc. common stock. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:48 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 2,738 | $135.00 | $369,630.00 |
DisclosureSEC source: 0001410384-21-000025 · wf-form4_161420687698893.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,492 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · shares: Includes shares sold to cover tax withholding obligations triggered upon lapse of restricted stock units. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.49 to $136.48 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 21:50 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionStock Option (right to buy) · Derivative | 1,943 | $0.00 Strike: $35.80 | $0.00 |
DisclosureSEC source: 0001410384-20-000179 · wf-form4_160763704034409.xml · derivative · entry 5 Breeden John E · CIK 0001597609 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,397 Underlying: Common Stock · 1,943 shares Expires 2024-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option grant vested as to 1/4 of the total option grant on February 21, 2018, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 21:50 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionStock Option (right to buy) · Derivative | 1,580 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0001410384-20-000179 · wf-form4_160763704034409.xml · derivative · entry 4 Breeden John E · CIK 0001597609 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,580 shares Expires 2023-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option grant vested as to 1/4 of the total option grant on February 16, 2017, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 21:50 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Tax withholdingCommon Stock | 873 | $114.73 | $100,159.29 |
DisclosureSEC source: 0001410384-20-000179 · wf-form4_160763704034409.xml · nonDerivative · entry 3 Breeden John E · CIK 0001597609 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,230 Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 21:50 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionCommon Stock | 1,943 | $35.80 | $69,559.40 |
DisclosureSEC source: 0001410384-20-000179 · wf-form4_160763704034409.xml · nonDerivative · entry 2 Breeden John E · CIK 0001597609 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 21:50 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionCommon Stock | 1,580 | $19.26 | $30,430.80 |
DisclosureSEC source: 0001410384-20-000179 · wf-form4_160763704034409.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 20:33 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionStock Option (right to buy) · Derivative | 7,614 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0001410384-20-000119 · wf-form4_159545000257573.xml · derivative · entry 3 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,580 Underlying: Common Stock · 7,614 shares Expires 2023-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option grant vests as to 1/4 of the total option grant on February 16, 2017, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 20:33 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 7,614 | $93.00 | $708,102.00 |
DisclosureSEC source: 0001410384-20-000119 · wf-form4_159545000257573.xml · nonDerivative · entry 2 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,580 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 20:33 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionCommon Stock | 7,614 | $19.26 | $146,645.64 |
DisclosureSEC source: 0001410384-20-000119 · wf-form4_159545000257573.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:39 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | GrantCommon Stock | 11,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001410384-20-000056 · wf-form4_158447753840742.xml · nonDerivative · entry 2 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,580 F2 · shares: Shares of stock acquired represent shares underlying Restricted Stock Units. The Restricted Stock Units vest annually in four equal installments beginning March 3, 2021. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:39 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | GrantCommon Stock | 11,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001410384-20-000056 · wf-form4_158447753840742.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,439 F1 · shares: Represents a grant of performance-based restricted stock units ("Units") under the 2014 Equity Incentive Plan. The target number of Units is presented in the table ("Target Amount"). Subject to continued employment, one-third (1/3) of the Target Amount is scheduled to vest annually ("Scheduled Amount"), on or about March 6th of each of 2021, 2022 and 2023. In each of the first two years the number of Units that actually vests will be 0% to 100% of the Scheduled Amount, and in the third year the number of Units that actually will vest will be 0% to 200% of the Target Amount, less the amount of any vesting in the first two years, in each case depending upon the performance of Q2 Holdings, Inc.'s common stock price as compared to the Russell 2000 Index, as more specifically set forth in the grant agreement. The maximum number of Units that may vest over three years is 200% of the Target Amount. Vested Units will be paid in an equal number of shares of Q2 Holdings, Inc. common stock. Read SEC document |
| March 10, 2020 Filed Mar 13, 2020 01:04 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 9,122 | $66.75 | $608,893.50 |
DisclosureSEC source: 0001410384-20-000050 · wf-form4_158406148021516.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,298 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · shares: Includes shares sold to cover tax withholding obligations triggered upon lapse of restricted stock units. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.18 to $68.67 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 21:26 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 6,842 | $73.97 | $506,102.74 |
DisclosureSEC source: 0001410384-20-000040 · wf-form4_158352997968280.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,420 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · shares: Includes shares sold to cover tax withholding obligations triggered upon lapse of restricted stock units. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.995 to $77.25 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 22:47 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 2,737 | $85.90 | $235,108.30 |
DisclosureSEC source: 0001410384-20-000031 · wf-form4_158258444143838.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,262 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · shares: Includes shares sold to cover tax withholding obligations triggered upon lapse of restricted stock units. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.71 to $88.73 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 23:24 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 3,800 | $86.97 | $330,486.00 |
DisclosureSEC source: 0001410384-20-000015 · wf-form4_158224107965405.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,999 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · shares: Includes shares sold to cover tax withholding obligations triggered upon lapse of restricted stock units. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.45 to $87.67 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:36 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 2,000 | $82.02 | $164,040.00 |
DisclosureSEC source: 0001410384-19-000144 · wf-form4_157592738590308.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,799 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.50 to $82.68 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 21:47 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionStock Option (right to buy) · Derivative | 3,706 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0001410384-19-000139 · wf-form4_157376800748515.xml · derivative · entry 5 Breeden John E · CIK 0001597609 · EVP, Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,194 Underlying: Common Stock · 3,706 shares Expires 2023-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option grant vested as to 1/4 of the total option grant on 2/16/17, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 21:47 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,431 | $0.00 Strike: $20.19 | $0.00 |
DisclosureSEC source: 0001410384-19-000139 · wf-form4_157376800748515.xml · derivative · entry 4 Breeden John E · CIK 0001597609 · EVP, Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498 Underlying: Common Stock · 4,431 shares Expires 2022-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option grant vested as to 1/4 of the total option grant on 2/20/16, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 21:47 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Tax withholdingCommon Stock | 2,176 | $73.95 | $160,915.20 |
DisclosureSEC source: 0001410384-19-000139 · wf-form4_157376800748515.xml · nonDerivative · entry 3 Breeden John E · CIK 0001597609 · EVP, Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,799 Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 21:47 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionCommon Stock | 3,706 | $19.26 | $71,377.56 |
DisclosureSEC source: 0001410384-19-000139 · wf-form4_157376800748515.xml · nonDerivative · entry 2 Breeden John E · CIK 0001597609 · EVP, Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 21:47 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionCommon Stock | 4,431 | $20.19 | $89,461.89 |
DisclosureSEC source: 0001410384-19-000139 · wf-form4_157376800748515.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 21:59 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $20.19 | $0.00 |
DisclosureSEC source: 0001410384-19-000099 · wf-form4_156089517046611.xml · derivative · entry 6 Breeden John E · CIK 0001597609 · EVP, Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,929 Underlying: Common Stock · 5,000 shares Expires 2022-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option grant vests as to 1/4 of the total option grant on 2/20/16, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 21:59 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 5,000 | $78.25 | $391,250.00 |
DisclosureSEC source: 0001410384-19-000099 · wf-form4_156089517046611.xml · nonDerivative · entry 4 Breeden John E · CIK 0001597609 · EVP, Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,838 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 21:59 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionCommon Stock | 5,000 | $20.19 | $100,950.00 |
DisclosureSEC source: 0001410384-19-000099 · wf-form4_156089517046611.xml · nonDerivative · entry 3 Breeden John E · CIK 0001597609 · EVP, Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 21:59 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $20.19 | $0.00 |
DisclosureSEC source: 0001410384-19-000099 · wf-form4_156089517046611.xml · derivative · entry 5 Breeden John E · CIK 0001597609 · EVP, Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,929 Underlying: Common Stock · 5,000 shares Expires 2022-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option grant vests as to 1/4 of the total option grant on 2/20/16, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 21:59 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 5,000 | $75.50 | $377,500.00 |
DisclosureSEC source: 0001410384-19-000099 · wf-form4_156089517046611.xml · nonDerivative · entry 2 Breeden John E · CIK 0001597609 · EVP, Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,838 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 21:59 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionCommon Stock | 5,000 | $20.19 | $100,950.00 |
DisclosureSEC source: 0001410384-19-000099 · wf-form4_156089517046611.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2019 Filed Jun 1, 2019 00:31 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $20.19 | $0.00 |
DisclosureSEC source: 0001410384-19-000082 · wf-form4_155934908706885.xml · derivative · entry 3 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,929 Underlying: Common Stock · 5,000 shares Expires 2022-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option grant vests as to 1/4 of the total option grant on 2/20/16, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. Read SEC document |
| May 29, 2019 Filed Jun 1, 2019 00:31 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 15,000 | $73.69 | $1,105,350.00 |
DisclosureSEC source: 0001410384-19-000082 · wf-form4_155934908706885.xml · nonDerivative · entry 2 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,838 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.42 to $74.36 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 29, 2019 Filed Jun 1, 2019 00:31 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionCommon Stock | 5,000 | $20.19 | $100,950.00 |
DisclosureSEC source: 0001410384-19-000082 · wf-form4_155934908706885.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 21:41 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0001410384-19-000058 · wf-form4_155415489303945.xml · derivative · entry 3 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,900 Underlying: Common Stock · 5,000 shares Expires 2023-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 21:41 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 5,000 | $68.57 | $342,850.00 |
DisclosureSEC source: 0001410384-19-000058 · wf-form4_155415489303945.xml · nonDerivative · entry 2 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,838 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.89 to $69.22 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 21:41 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionCommon Stock | 5,000 | $19.26 | $96,300.00 |
DisclosureSEC source: 0001410384-19-000058 · wf-form4_155415489303945.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 21:57 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 4,723 | $68.82 | $325,036.86 |
DisclosureSEC source: 0001410384-19-000055 · wf-form4_155260061304253.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,838 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · shares: Includes shares sold to cover tax withholding obligations triggered upon lapse of restricted stock units. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.03 to $69.52 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 22:25 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | GrantCommon Stock | 13,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001410384-19-000039 · wf-form4_155208394080825.xml · nonDerivative · entry 2 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,561 F2 · shares: Shares of stock acquired represent shares underlying Restricted Stock Units. The Restricted Stock Units vest annually in four equal installments beginning March 3, 2020. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 22:25 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | GrantCommon Stock | 13,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001410384-19-000039 · wf-form4_155208394080825.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,364 F1 · shares: Represents a grant of performance-based restricted stock units ("Units") under the 2014 Equity Incentive Plan. The target number of Units is presented in the table ("Target Amount"). Subject to continued employment, one-third (1/3) of the Target Amount is scheduled to vest annually ("Scheduled Amount"), on or about March 6th of each of 2020, 2021 and 2022. In each of the first two years the number of Units that actually vests will be 0% to 100% of the Scheduled Amount, and in the third year the number of Units that actually will vest will be 0% to 200% of the Target Amount, less the amount of any vesting in the first two years, in each case depending upon the performance of Q2 Holdings, Inc.'s common stock price as compared to the Russell 2000 Index, as more specifically set forth in the grant agreement. The maximum number of Units that may vest over three years is 200% of the Target Amount. Vested Units will be paid in an equal number of shares of Q2 Holdings, Inc. common stock. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 22:27 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 3,542 | $68.06 | $241,068.52 |
DisclosureSEC source: 0001410384-19-000031 · wf-form4_155191123342345.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,167 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · shares: Includes shares sold to cover tax withholding obligations triggered upon lapse of restricted stock units. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.61 to $70.59 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 21, 2019 Filed Feb 21, 2019 22:42 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 6,238 | $65.30 | $407,341.40 |
DisclosureSEC source: 0001410384-19-000021 · wf-form4_155078894988321.xml · nonDerivative · entry 2 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,709 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · shares: Includes shares sold to cover tax withholding obligations triggered upon lapse of restricted stock units. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.45 to $65.84 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:42 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 3,800 | $64.97 | $246,886.00 |
DisclosureSEC source: 0001410384-19-000021 · wf-form4_155078894988321.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,947 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · shares: Includes shares sold to cover tax withholding obligations triggered upon lapse of restricted stock units. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.60 to $65.30 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 24, 2019 Filed Jan 25, 2019 22:07 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0001410384-19-000007 · wf-form4_154845405920529.xml · derivative · entry 3 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,900 Underlying: Common Stock · 5,000 shares Expires 2023-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2019 Filed Jan 25, 2019 22:07 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 5,000 | $55.97 | $279,850.00 |
DisclosureSEC source: 0001410384-19-000007 · wf-form4_154845405920529.xml · nonDerivative · entry 2 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,747 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.54 to $56.30 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 24, 2019 Filed Jan 25, 2019 22:07 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionCommon Stock | 5,000 | $19.26 | $96,300.00 |
DisclosureSEC source: 0001410384-19-000007 · wf-form4_154845405920529.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 23:10 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0001410384-18-000114 · wf-form4_154266902333291.xml · derivative · entry 3 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,900 Underlying: Common Stock · 7,500 shares Expires 2023-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option grant vested as to 1/4 of the total option grant on February 16, 2017, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 23:10 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 7,500 | $50.58 | $379,350.00 |
DisclosureSEC source: 0001410384-18-000114 · wf-form4_154266902333291.xml · nonDerivative · entry 2 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,747 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.90 to $51.27 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 23:10 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionCommon Stock | 7,500 | $19.26 | $144,450.00 |
DisclosureSEC source: 0001410384-18-000114 · wf-form4_154266902333291.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 22:39 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0001410384-18-000107 · wf-form4_153972954887162.xml · derivative · entry 3 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,400 Underlying: Common Stock · 7,500 shares Expires 2023-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option grant vested as to 1/4 of the total option grant on February 16, 2017, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 22:39 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 7,500 | $50.33 | $377,475.00 |
DisclosureSEC source: 0001410384-18-000107 · wf-form4_153972954887162.xml · nonDerivative · entry 2 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,747 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.55 to $51.60 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 22:39 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | Exercise / conversionCommon Stock | 7,500 | $19.26 | $144,450.00 |
DisclosureSEC source: 0001410384-18-000107 · wf-form4_153972954887162.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 20:53 UTC | Q2 Holdings, Inc. QTWO · Entity 4051 | SaleCommon Stock | 10,000 | $62.41 | $624,100.00 |
DisclosureSEC source: 0001410384-18-000091 · wf-form4_153574881394949.xml · nonDerivative · entry 1 Breeden John E · CIK 0001597609 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,747 F1 · kind: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.675 to $63.45 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.